Etafenone: Difference between revisions
CSV import |
No edit summary |
||
| Line 40: | Line 40: | ||
{{stub}} | {{stub}} | ||
<gallery> | <gallery> | ||
File:Etafenone.svg|Etafenone | File:Etafenone.svg|Etafenone | ||
</gallery> | </gallery> | ||
Latest revision as of 20:52, 16 March 2025
Etafenone is a cardiac stimulant used in the treatment of angina pectoris. It is classified as an antiarrhythmic agent, and is also used to alleviate symptoms of cardiac arrhythmia. Etafenone works by improving the metabolic processes in the myocardium, thereby enhancing the heart's efficiency.
Mechanism of Action[edit]
Etafenone acts by inhibiting the sodium-potassium pump in the myocardial cells. This results in an increase in the intracellular concentration of calcium ions, which in turn enhances the contractility of the heart muscle. Additionally, Etafenone also has a vasodilatory effect, which helps to reduce the workload on the heart.
Indications[edit]
Etafenone is primarily used in the treatment of:
Side Effects[edit]
Like all medications, Etafenone can cause side effects. These may include:
Contraindications[edit]
Etafenone should not be used in patients with:
- Hypersensitivity to Etafenone
- Severe heart failure
- Cardiogenic shock
- Sick sinus syndrome without a pacemaker
Interactions[edit]
Etafenone may interact with other medications, including:


